2007 Review
More Interaction between China and International Pharmaceutical Industry
Over 300 professionals attended the 2-day conference and workshop of the "CPhI China 2007 • International Forum" (the Forum) organized by CMPi (Netherland) and Pacific Genuity (San Carlos, CA) during June 19-20, 2007 at Shanghai New International Exhibition Center. They discussed about hot topics of pharmaceutical industry such as corporate growth, market exploration, and global procurement.
The portfolio of business development and cGMP training has attracted overseas attendees and corporate executives, accounting for 13% and 65% of the total number, respectively. They come to the forum for updated business trends and networking with industry counterparts.
C-level representatives from leading international and Chinese pharmaceutical companies, such as Steve Yang, head of research, Asia, Pfizer Global Research and Development, and David Wu, v.p. of Shanghai Pharmaceutical, give speeches in the conference. Most speakers from Chinese companies have overseas work experience, such as Qian Ou, director of GeneScience Pharmaceutical, one of China's largest growth hormone manufacturers.
China has been a major supplier of APIs and pharmaceutical intermediates to global market. Now more international pharmaceutical companies are eyeing China for research and development services. Steve Yang talks about outsourcing pharmaceutical R&D to China. Meanwhile, Li Chen, CSO of Roche R&D China, speaks specifically about drug discovery research in China.
More and more Chinese pharmaceutical companies have started to participate in global competition, and certification from FDA is a must to the access of US pharmaceutical market. The workshop of the forum is designed to help Chinese companies and regulatory bodies understand cGMP system. Many workshop attendees express their hope for more such trainings.
The forum can be regarded as a success as it meets the needs of Chinese and international industry players by offering a platform of information exchange and networking. International firms are concerned about taking advantage of the low labor cost, vast market, and booming economy of China; Chinese firms are enthusiastic about gaining various international certifications and selling their products to global market.
